XOFLUZA Specified Drug Use-results Survey (high-risk subjects in prophylaxis use)

XOFLUZA Specified Drug Use-results Survey (high-risk subjects in prophylaxis use) - XOFLUZA Specified Drug Use-results Survey (high-risk subjects in prophylaxis use)

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000042673

Enrollment

120

Registered

2020-12-25

Start date

2021-01-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prophylaxis for influenza virus infection

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Household members at specific high-risk who live with an influenza-infected index patient

Exclusion criteria

Exclusion criteria: NA

Design outcomes

Primary

Measure	Time frame
Incidence rates of adverse drug reactions for household members at specific high-risk of XOFLUZA in prophylaxis use	—

Secondary

Measure	Time frame
Prevalence rates of influenza virus infections for household members at specific high-risk of XOFLUZA in prophylaxis use	—

Countries

Japan

Contacts

Public ContactKanae Hara

Shionogi & Co., Ltd. Pharmacovigilance Department

kanae.hara@shionogi.co.jp+81-6-6209-6974

Outcome results